IMDNA provides scientific, technical, and non-regulatory support for documentation and technology transfer of molecular assays, qPCR/RT-qPCR reagents, controls, immunoassays, flow-cytometry workflows, cell-based assays, manufacturing processes, research-use kits, analytical procedures, and laboratory methods within IMDNA's technical capabilities. Support can include gap assessment, transfer planning, technical-document packages, SOPs and work instructions, manufacturing and batch documentation, assay design records, QC methods, transfer protocols, training materials, analytical comparison or bridging support, receiving-site readiness, deviation management, transfer reports, change documentation, and ongoing technical assistance.
Technology transfer is more than moving a file from one organization to another. WHO defines technology transfer as a logical procedure that transfers a product or process together with its documentation and professional expertise. A receiving team must understand not only what to do, but also why critical steps matter, which variables affect performance, what evidence supports the operating ranges, how problems are recognized, and how changes should be evaluated. IMDNA therefore treats documentation and knowledge transfer as one integrated technical process.
WHO's 2022 technology-transfer guideline describes transfer as the controlled movement of products, processes, knowledge, documentation, and professional expertise between development, manufacturing, or testing sites. It further states that transfer rigor should be appropriate to the product life-cycle phase and that knowledge should be maintained as processes move between units.
Transfer controlled documents, formulas, assay conditions, sequences, specifications, methods, data, reports, acceptance criteria, and defined operating ranges.
Transfer practical experience such as critical technique, troubleshooting logic, failure modes, instrument behavior, reagent sensitivities, and process nuances not fully captured in an SOP.
Clearly define the sending unit, receiving unit, technical owners, document owners, training responsibilities, review responsibilities, and decision pathways.
Use training, pilot work, analytical comparison, bridging, receiving-site runs, or other scientifically justified evidence to demonstrate that the receiving unit can reproduce the transferred procedure.
Preserve product/process history, change rationale, performance knowledge, and technical lessons so future updates remain traceable.
Support can be tailored to a customer-to-IMDNA transfer, IMDNA-to-customer transfer, internal site-to-site transfer, laboratory method transfer, OEM/private-label program, manufacturing handoff, or research collaboration.
Define what is being transferred, from which unit to which unit, the intended use, product or method configuration, expected deliverables, timeline, and technical boundaries.
Compare documentation, process knowledge, instruments, materials, facilities, software, training, controls, test methods, storage, packaging, and workflow between the sending and receiving units.
Develop a structured transfer plan describing scope, responsibilities, activities, study design, documentation, acceptance criteria, deviation handling, training, and close-out expectations.
Compile product/process descriptions, assay design records, formulas, specifications, SOPs, work instructions, QC procedures, analytical methods, data summaries, and supporting references.
Translate development knowledge into controlled, stepwise instructions suitable for the receiving workflow and subject to laboratory/manufacturer review and approval.
Support master manufacturing instructions, batch production records, material lists, in-process controls, filling/packaging instructions, sampling, storage, and traceability documents.
Support transfer of qPCR, RT-qPCR, immunoassay, flow-cytometry, cell-based, concentration, identity, or other technical methods used to evaluate product or assay performance.
Provide method-specific training, scientific rationale, practical demonstrations, troubleshooting guidance, and knowledge transfer to the receiving team.
Review whether the receiving unit has suitable equipment, materials, controls, software, training, documents, workflow, and technical resources to execute the transferred method or process.
Support pilot batches, engineering runs, assay runs, cross-validation, comparison studies, bridging studies, or other activities used to demonstrate transfer performance.
Help document unexpected events, analyze technical impact, investigate root causes, define additional work, and determine whether transfer conclusions remain supported.
Summarize transfer activities, results, deviations, acceptance criteria, unresolved items, conclusions, responsibilities, and follow-up actions in a controlled transfer report.
IMDNA's support framework follows a lifecycle approach from project initiation through knowledge capture, transfer execution, documented evidence, and close-out.
WHO identifies documentation as a principal component of technology transfer. The exact document set should be proportionate to the product, method, process, life-cycle stage, and receiving-unit needs.
Scientific principle, intended research use, analyte or target, sequence or formulation information, sample/material type, workflow, critical characteristics, and known limitations.
Raw-material, intermediate, in-process, functional, analytical, packaging, storage, and other defined technical criteria relevant to the transferred product or procedure.
Stepwise operating procedures supported by equipment, setup, safety, cleaning, maintenance, sampling, analysis, and troubleshooting instructions where appropriate.
Formulas, master instructions, batch records, material requirements, process parameters, hold points, filling, packaging, labeling, and yield information.
Test methods, control strategy, reference materials, calculations, acceptance criteria, instrument settings, data analysis, and result-reporting templates.
Feasibility, optimization, analytical verification/validation, robustness, scale-up, stability, troubleshooting, or comparison data that support the transferred method.
Slide decks, demonstrations, job aids, troubleshooting guides, technical notes, competency tools, FAQs, and practical knowledge that may not fit inside the SOP.
Document historical changes, rationale, technical impact, comparison studies, document revisions, and current approved configuration.
WHO's current technology-transfer guidance explicitly includes due diligence and gap analysis. A receiving unit should understand where its equipment, materials, documentation, environment, or experience differ from those used to develop the original process.
| Transfer Area | Questions to Evaluate | Potential IMDNA Support |
|---|---|---|
| Documents | Are current procedures, specifications, data, change histories, reports, and technical references available and internally consistent? | Document inventory, gap list, document harmonization, template development. |
| Equipment / Instrumentation | Are the same instruments available? If not, could platform differences affect performance? | Equipment comparison, settings review, bridging/comparison study planning. |
| Raw Materials / Reagents | Are suppliers, grades, lots, formulations, oligonucleotides, antibodies, enzymes, buffers, plastics, or controls equivalent? | Material mapping, alternate-source review, comparability testing support. |
| Facility / Environment | Could temperature, humidity, contamination control, clean/dirty flow, utilities, storage, or workspace affect the process? | Technical workflow review, risk identification, readiness checklist. |
| Personnel | Does the receiving team understand the method, critical steps, failure modes, and troubleshooting approach? | Training plan, technical orientation, guided practice, knowledge-transfer materials. |
| Software / Data Analysis | Are software versions, analysis settings, thresholds, gating strategies, calculations, or reporting workflows equivalent? | Software/configuration documentation, data-analysis transfer, comparison support. |
| Scale / Throughput | Will batch size, sample volume, fill duration, assay throughput, or staffing materially change? | Scale-impact review, pilot studies, workflow optimization, documentation updates. |
WHO frames technology transfer around a sending unit and receiving unit. The sending unit should provide enough controlled knowledge for the receiving unit to understand and reproduce the transferred process or procedure.
The receiving unit should demonstrate that the necessary people, equipment, materials, controls, documents, and workflow are available before routine execution.
WHO states that analytical-procedure transfer may use confirmation testing, comparability testing between sending and receiving units, co-validation, or in appropriate circumstances a documented knowledge-based transfer. The strategy should be risk based and scientifically justified. For qPCR/RT-qPCR and other research assays, IMDNA can help translate that principle into a method-specific transfer plan.
Transfer sequences, oligonucleotide concentrations, master mix, cycling, channels, thresholds, controls, reference materials, extraction/sample preparation, acceptance criteria, and troubleshooting logic.
Transfer multiplex architecture, target ratios, fluorophore assignments, instrument compatibility, weak-target performance, internal-control balance, and channel behavior.
Transfer reagents, standards, controls, sample dilution, plate setup, incubation, wash, detection, reader settings, calculation, and analytical acceptance workflow.
Transfer bead identity, calibrators, analyte ranges, sample dilution, incubation, washing, acquisition, instrument settings, data reduction, and analyte-specific QC.
Transfer sample preparation, antibody clones, fluorochrome assignments, compensation/unmixing, instrument setup, controls, acquisition, gating logic, data review, and troubleshooting.
Transfer cell identity, culture conditions, passage window, plating density, treatment, timing, controls, readout, instrument settings, and critical biological handling knowledge.
WHO's technology-transfer framework covers production, packaging, analytical testing, equipment, documentation, qualification, and validation. For IMDNA research-product projects, these principles can support transfer of reagent manufacturing and assembly processes without implying that every project is a pharmaceutical GMP transfer.
Transfer composition, calculations, order of addition, mixing conditions, temperature, pH, hold time, filtration, stabilization, and storage requirements.
Transfer batch instructions, materials, equipment, process parameters, in-process controls, yield expectations, sampling, and batch records.
Transfer dispense volumes, fill order, agitation, dead-volume considerations, beginning/middle/end checks, container configuration, and fill documentation.
Transfer BOM, component layout, labels, artwork versions, storage configuration, inserts, pack checks, lot mapping, and packaging instructions.
Transfer the methods used to evaluate raw materials, in-process samples, reagents, controls, multiplex performance, lot comparability, and internal lot-disposition criteria.
Transfer pilot-scale observations, scale-dependent risks, mixing, hold-time, filling, transfer loss, sampling, stability, and troubleshooting experience.
ICH Q10 identifies knowledge management as an enabler of a pharmaceutical quality system, and ISPE highlights it as a critical element of successful technology transfer. The principle is broadly useful: a transfer should preserve the reasons behind technical decisions, not only the final settings.
Record why specific sequences, reagents, controls, concentrations, process parameters, instruments, materials, or operating ranges were selected.
Preserve successful and unsuccessful experiments that explain the current configuration and prevent future teams from repeating avoidable failures.
Document signs of degradation, inhibition, cross-reactivity, drift, contamination, lot variability, cell-state changes, or other recurring technical risks.
Transfer diagnostic reasoning used to distinguish reagent, instrument, matrix, operator, software, sample, or process problems.
Develop practical materials that can support new staff after the formal transfer project is closed.
Maintain a controlled repository of current documents, historical reports, changes, comparisons, lessons learned, and supporting scientific references.
WHO defines a technology-transfer report as a documented summary of the transfer project that lists procedures, acceptance criteria, results, and conclusions. Transfer should not be considered complete simply because documents were delivered; open technical issues, deviations, training needs, and unresolved comparability questions should be addressed or formally documented.
| Close-Out Element | Purpose | Potential IMDNA Support |
|---|---|---|
| Acceptance-Criteria Review | Confirm whether predefined transfer objectives were met. | Technical data review, comparison summaries, criteria tables. |
| Deviation Review | Determine whether deviations affected the scientific validity or transfer conclusion. | Deviation documentation, impact review, additional study planning. |
| Open-Item Resolution | Close unresolved training, equipment, documentation, material, or analytical gaps. | Action list, owner assignment, follow-up documentation. |
| Change Documentation | Document any changes introduced during transfer and their technical rationale. | Change summary, bridging-study documentation, revised procedures. |
| Transfer Report | Create a controlled record of activities, results, conclusions, and remaining responsibilities. | Transfer-report drafting and technical summary support. |
| Post-Transfer Monitoring | Confirm continued performance after routine operation begins. | Early-run review, troubleshooting, lot comparison, ongoing technical support. |
IMDNA provides scientific, technical, documentation, knowledge-transfer, method-transfer, manufacturing-transfer, training, troubleshooting, analytical-comparison, technology-transfer, and non-regulatory support based on the needs of each project. Support may include assistance with transfer-scope definition, due diligence and gap assessment, transfer plans and protocols, technical-document packages, SOPs, work instructions, manufacturing/batch documents, analytical/QC methods, training resources, receiving-site readiness, pilot or comparison studies, deviation review, transfer reports, change documentation, and post-transfer technical support.
Where appropriate, IMDNA may act as a sending unit, receiving unit, development partner, contract manufacturer, research-assay developer, or technical-support organization under the defined project arrangement. The exact responsibilities should be documented for each transfer.
IMDNA is not a regulatory, licensing, accreditation, certification, legal, intellectual-property, governmental, or inspecting authority. IMDNA does not independently determine that a transferred product, process, assay, method, label, manufacturing operation, or receiving site satisfies every applicable requirement, and does not guarantee regulatory acceptance or market authorization.
The responsible product owner, laboratory, manufacturer, or receiving organization remains responsible for determining applicable requirements; approving transfer plans, specifications, acceptance criteria, procedures, and final conclusions; authorizing method or process use; controlling proprietary or confidential information; and obtaining any required regulatory, legal, licensing, accreditation, certification, registration, listing, or other approval.
WHO, ICH, FDA, and ISPE references on this page are used as science-, quality-, and knowledge-management frameworks. Their formal regulatory applicability depends on the product category, life-cycle stage, intended use, jurisdiction, and responsible organization. Inclusion of these references does not imply that every IMDNA technology-transfer project is a pharmaceutical GMP transfer.
References to governmental, regulatory, standards-development, scientific, or professional organizations are provided for general informational purposes only and do not imply endorsement, approval, affiliation, certification, or sponsorship of IMDNA or its services.
The following sources support the general concepts of documentation, knowledge management, due diligence, gap analysis, analytical and manufacturing transfer, training, change management, and transfer reporting. Several are pharmaceutical-sector frameworks; their formal applicability depends on the specific product and project.
Tell IMDNA what is being transferred, the sending and receiving units, assay or product type, manufacturing or analytical process, instruments, materials, controls, existing documents, current performance data, known failure modes, receiving-site differences, training needs, and transfer objectives. Our scientific and technical team can help organize a documentation and technology-transfer program covering gap analysis, controlled documents, SOPs, manufacturing and QC methods, training, pilot/comparison work, deviation review, transfer reporting, and post-transfer support.